Post-approval studies (Phase 4)Ended earlyNCT01812759What this trial is testingFentanyl for Breakthrough Pain in the Emergency DepartmentWho this might be right forPain M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00015964What this trial is testingZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and NeckWho this might be right forHead and Neck Cancer University of Chicago 51
Testing effectiveness (Phase 2)Study completedNCT00005087What this trial is testingPaclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Radiation Therapy Oncology Group 105
Testing effectiveness (Phase 2)Study completedNCT02825147What this trial is testingPegaspargase and Methotrexate Based Regimens for Newly Diagnosed Extranodal NK/T Cell LymphomaWho this might be right forNasal Type Extranodal NK/T-Cell Lymphoma Ruijin Hospital 40
Early research (Phase 1)WithdrawnNCT01728480What this trial is testingEntolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation TherapyWho this might be right forMucositisRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+35 more Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00007982What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System CancerWho this might be right forBrain and Central Nervous System TumorsHead and Neck CancerLymphoma Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT00890747What this trial is testingSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT00629226What this trial is testingBortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 46
Not applicableLooking for participantsNCT05495048What this trial is testingTransvaginal NOSES Versus Conventional Laparoscopic Surgery for Right HemicolectomyWho this might be right forColon Cancer Shanghai Minimally Invasive Surgery Center 356
Testing effectiveness (Phase 2)Looking for participantsNCT06980038What this trial is testingTesting Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck CancerWho this might be right forHead and Neck Squamous Cell CarcinomaHypopharyngeal Squamous Cell CarcinomaLaryngeal Squamous Cell Carcinoma+19 more National Cancer Institute (NCI) 44
Not applicableEnded earlyNCT02388932What this trial is testingStereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma+25 more Case Comprehensive Cancer Center 3
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Not applicableNo Longer AvailableNCT00423826What this trial is testingUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT01313390What this trial is testingEverolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University College, London 4
Not applicableEnrolling By InvitationNCT06906952What this trial is testingA Prospective Single-center Randomized Controlled Trial of Robotic Surgery With Transrectal Resection Specimens (NOSES-IV) and Traditional Assisted Robotic Surgery for the Treatment of High Rectal and Sigmoid Colon CancerWho this might be right forNatural Orifice Specimen Extraction SurgeryRobotic SurgeryShort-term Outcomes Nanchang University 100
Not applicableStudy completedNCT00021138What this trial is testingComputer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop SmokingWho this might be right forEsophageal CancerHead and Neck CancerLung Cancer Personal Improvement Computer Systems
Not applicableStudy completedNCT00002520What this trial is testingPhysician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT00470496What this trial is testingPhotodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity+52 more Roswell Park Cancer Institute 15
Large-scale testing (Phase 3)WithdrawnNCT04021082What this trial is testingCELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)Who this might be right forPeripheral T-Cell Lymphoma (PTCL NOS)Nodal Lymphomas of T Follicular Helper (TFH)Follicular T-cell Lymphoma (FTCL)+6 more Portola Pharmaceuticals